ATE273022T1 - Verfahren zur verstärkung zellularer immunantworten - Google Patents
Verfahren zur verstärkung zellularer immunantwortenInfo
- Publication number
- ATE273022T1 ATE273022T1 AT93921698T AT93921698T ATE273022T1 AT E273022 T1 ATE273022 T1 AT E273022T1 AT 93921698 T AT93921698 T AT 93921698T AT 93921698 T AT93921698 T AT 93921698T AT E273022 T1 ATE273022 T1 AT E273022T1
- Authority
- AT
- Austria
- Prior art keywords
- immune responses
- cellular immune
- enhancing cellular
- enhancing
- immunogen
- Prior art date
Links
- 230000002708 enhancing effect Effects 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 230000001413 cellular effect Effects 0.000 title 1
- 230000002163 immunogen Effects 0.000 abstract 2
- 241001465754 Metazoa Species 0.000 abstract 1
- 241000204031 Mycoplasma Species 0.000 abstract 1
- 241000282898 Sus scrofa Species 0.000 abstract 1
- 230000021633 leukocyte mediated immunity Effects 0.000 abstract 1
- 230000004044 response Effects 0.000 abstract 1
- 238000002255 vaccination Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/0241—Mollicutes, e.g. Mycoplasma, Erysipelothrix
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
- A61K2039/552—Veterinary vaccine
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Mycology (AREA)
- Organic Chemistry (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Control Of Motors That Do Not Use Commutators (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compounds Of Unknown Constitution (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Steroid Compounds (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US95224892A | 1992-09-28 | 1992-09-28 | |
| PCT/US1993/008900 WO1994007531A1 (en) | 1992-09-28 | 1993-09-21 | Method of enhancing cell mediated immune responses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE273022T1 true ATE273022T1 (de) | 2004-08-15 |
Family
ID=25492700
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT93921698T ATE273022T1 (de) | 1992-09-28 | 1993-09-21 | Verfahren zur verstärkung zellularer immunantworten |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP0839050B1 (enFirst) |
| JP (1) | JPH08502253A (enFirst) |
| AT (1) | ATE273022T1 (enFirst) |
| AU (1) | AU687750B2 (enFirst) |
| CA (1) | CA2145760A1 (enFirst) |
| DE (1) | DE69333588T2 (enFirst) |
| DK (1) | DK0839050T3 (enFirst) |
| ES (1) | ES2225825T3 (enFirst) |
| MX (1) | MX9306016A (enFirst) |
| PT (1) | PT839050E (enFirst) |
| WO (1) | WO1994007531A1 (enFirst) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7060284B1 (en) | 1999-08-03 | 2006-06-13 | The Ohio State University | Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
| TNSN03155A1 (fr) | 2001-07-02 | 2005-12-23 | Pfizer Prod Inc | Vaccination unidose avec mycoplasma hyopneumoniae |
| US8834891B2 (en) | 2005-03-14 | 2014-09-16 | Boehringer Ingelheim Vetmedica, Inc. | Immunogenic compositions comprising Lawsonia intracellularis |
| JP5222134B2 (ja) | 2005-06-15 | 2013-06-26 | ザ オハイオ ステート ユニバーシティー リサーチ ファウンデーション | Ｈｅｒ−２ペプチド |
| US8398994B2 (en) * | 2005-07-15 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Lawsonia vaccine and methods of use thereof |
| US8470336B2 (en) | 2006-05-25 | 2013-06-25 | Boehringer Ingelheim Vetmedica, Inc. | Vaccination of young animals against Lawsonia intracellularis infections |
| US8398970B2 (en) | 2007-09-17 | 2013-03-19 | Boehringer Ingelheim Vetmedica, Inc. | Method of preventing early Lawsonia intracellularis infections |
| US20100234283A1 (en) | 2009-02-04 | 2010-09-16 | The Ohio State University Research Foundation | Immunogenic epitopes, peptidomimetics, and anti-peptide antibodies, and methods of their use |
| WO2011141443A1 (en) | 2010-05-11 | 2011-11-17 | Intervet International B.V. | Vaccine against mycoplasma hyopneumoniae, suitable for administration in the presence of maternally derived antibodies |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4894332A (en) * | 1985-03-27 | 1990-01-16 | Biogen, Inc. | DNA sequences coding for Mycoplasma hypopneumoniae surface antigens, methods of use to make the corresponding proteins |
| US4985243A (en) * | 1988-01-20 | 1991-01-15 | Ml Technology Ventures, L.P. | Composition and method for protecting against diseases caused by microorganisms |
| US4981684A (en) * | 1989-10-24 | 1991-01-01 | Coopers Animal Health Limited | Formation of adjuvant complexes |
| CA2082155C (en) * | 1990-05-29 | 2008-04-15 | Krishnaswamy I. Dayalu | Swine pneumonia vaccine and method of preparation |
| US5565205A (en) * | 1990-08-16 | 1996-10-15 | Solvay Animal Health, Inc. | Inactivated Mycoplasma hypopneumoniae bacterin and method of use thereof |
-
1993
- 1993-09-21 DK DK93921698T patent/DK0839050T3/da active
- 1993-09-21 CA CA002145760A patent/CA2145760A1/en not_active Abandoned
- 1993-09-21 DE DE69333588T patent/DE69333588T2/de not_active Expired - Lifetime
- 1993-09-21 AT AT93921698T patent/ATE273022T1/de active
- 1993-09-21 EP EP93921698A patent/EP0839050B1/en not_active Expired - Lifetime
- 1993-09-21 AU AU49312/93A patent/AU687750B2/en not_active Expired
- 1993-09-21 ES ES93921698T patent/ES2225825T3/es not_active Expired - Lifetime
- 1993-09-21 PT PT93921698T patent/PT839050E/pt unknown
- 1993-09-21 JP JP6509128A patent/JPH08502253A/ja active Pending
- 1993-09-21 WO PCT/US1993/008900 patent/WO1994007531A1/en not_active Ceased
- 1993-09-28 MX MX9306016A patent/MX9306016A/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ES2225825T3 (es) | 2005-03-16 |
| AU4931293A (en) | 1994-04-26 |
| WO1994007531A1 (en) | 1994-04-14 |
| EP0839050B1 (en) | 2004-08-11 |
| DE69333588T2 (de) | 2005-08-04 |
| DE69333588D1 (de) | 2004-09-16 |
| DK0839050T3 (da) | 2004-10-25 |
| MX9306016A (es) | 1995-01-31 |
| JPH08502253A (ja) | 1996-03-12 |
| EP0839050A1 (en) | 1998-05-06 |
| PT839050E (pt) | 2004-11-30 |
| EP0839050A4 (enFirst) | 1998-05-06 |
| CA2145760A1 (en) | 1994-04-14 |
| AU687750B2 (en) | 1998-03-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2059369T3 (es) | Formulacion de vacuna. | |
| SG46445A1 (en) | Vaccines against cancer and infectious diseases | |
| ATE127345T1 (de) | Stressproteine und verwendungen dafür. | |
| EE200100203A (et) | Meetod immuunvastuse indutseerimiseks polüpeptiidse antigeeni vastu ja rakuga seotud polüpeptiidse antigeeni mahasurumiseks loomorganismil, selle meetodi kasutamine eesnäärme- ja rinnavähi raviks ning immunogeenne kompositsioon | |
| DK157087A (da) | Multivalent vaccine, isaer herpesvirusvaccine, dens anvendelse og deri indgaaende virus | |
| FI943171A0 (fi) | Ureaasipohjainen rokote Helicobacter-infektiota vastaan | |
| ATE203677T1 (de) | Legionellosis-impfstoffe und verfahren zur deren herstellung | |
| ATE475668T1 (de) | Immunisierung durch impfung von dns transkriptionseinheit | |
| DE3486292D1 (de) | Tierärztliche Impfstoffe. | |
| ATE273022T1 (de) | Verfahren zur verstärkung zellularer immunantworten | |
| ID21338A (id) | Metoda untuk menghasilkan kekebalan aktif dengan vaksin gabungan | |
| ATE196425T1 (de) | Impfstoff gegen die lyme-krankheit | |
| DK16087D0 (da) | Mastitis-vaccine | |
| DE3467813D1 (en) | Diagnostic antigen for swine pseudorabies disease virus carriers | |
| ATE109004T1 (de) | Toleranzinduktion gegenüber einem fremdantigen. | |
| EP0636030A4 (en) | VACCINE AGAINST THE -I BACTERIAL OXIDE (PASTEURELLIA HAEMOLYTICA). | |
| EP0339040A4 (en) | Swine dysentery vaccine. | |
| Toma et al. | Vaccination of dogs against rabies. Comparison of serological responses one year after intradermal or subcutaneous vaccination | |
| ATE152916T1 (de) | Die verwendung von anti-helminth impfstoffen zur kontrolle von parasitären krankheiten, die mit einem verlust der natürlichen immunität assoziiert sind | |
| DK49685A (da) | Fremgangsmaade til fremstilling af en modificeret levende pasteurella haemolytica vaccine | |
| RU93008069A (ru) | Способ иммунизации крупного рогатого скота |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 0839050 Country of ref document: EP |